These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29449527)
1. TR Jin R; Lin H; Li G; Xu J; Shi L; Chang C; Cai X Cell Death Dis; 2018 Feb; 9(3):283. PubMed ID: 29449527 [TBL] [Abstract][Full Text] [Related]
2. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth. Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071 [TBL] [Abstract][Full Text] [Related]
3. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852 [TBL] [Abstract][Full Text] [Related]
4. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression. Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838 [TBL] [Abstract][Full Text] [Related]
5. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals. Qiu X; Zhu J; Sun Y; Fan K; Yang DR; Li G; Yang G; Chang C Oncotarget; 2015 Jun; 6(17):15397-409. PubMed ID: 25980442 [TBL] [Abstract][Full Text] [Related]
6. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression. Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521 [TBL] [Abstract][Full Text] [Related]
7. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling. Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468 [TBL] [Abstract][Full Text] [Related]
8. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma. Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138 [TBL] [Abstract][Full Text] [Related]
9. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133 [TBL] [Abstract][Full Text] [Related]
10. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. Lin WJ; Li J; Lee YF; Yeh SD; Altuwaijri S; Ou JH; Chang C J Biol Chem; 2003 Mar; 278(11):9353-60. PubMed ID: 12522137 [TBL] [Abstract][Full Text] [Related]
11. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. Li H; Sun Q; Han B; Yu X; Hu B; Hu S Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168 [TBL] [Abstract][Full Text] [Related]
12. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer. Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451 [TBL] [Abstract][Full Text] [Related]
13. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals. Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427 [TBL] [Abstract][Full Text] [Related]
14. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease. Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479 [TBL] [Abstract][Full Text] [Related]
15. miR‑141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression. Li G; Huang M; Cai Y; Ke Y; Yang Y; Sun X Mol Med Rep; 2018 Aug; 18(2):1395-1404. PubMed ID: 29901110 [TBL] [Abstract][Full Text] [Related]
16. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524 [TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748 [TBL] [Abstract][Full Text] [Related]
18. EPHA2 Promotes the Invasion and Migration of Human Tongue Squamous Cell Carcinoma Cal-27 Cells by Enhancing AKT/mTOR Signaling Pathway. Wang F; Zhang H; Cheng Z Biomed Res Int; 2021; 2021():4219690. PubMed ID: 33834064 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice. Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367 [TBL] [Abstract][Full Text] [Related]
20. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells]. Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]